- Diagnostics
- Monday, 13 Apr 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Huami announced a collaboration with the Chinese National Center for Clinical Research on Lung Disease (NCRCRD) and the Guangdong Nanshan Institute for Medical Innovation, led by Dr. Nanshan Zhong, to establish a joint laboratory to develop smart portable devices. Relying on Huami's intelligent portable technologies and powerful calculation algorithms, the laboratory aims to help monitor and manage COVID-19 cured patients through the NCRCRD big data platform. In addition, the laboratory would jointly contribute to an alert and forecast system for epidemics.
"As a collaboration between medical institutes, research and development institutions and companies, we are excited to use our expertise in intelligent portable technologies to promote applied research and facilitate a real transformation in respiratory health" said Wang Huang , founder and chief executive officer of Huami Technology. Guided by its mission to “connect health to technology”, Huami is determined to create a global health ecosystem including devices, data and services, while being a trusted trusted partner of its users.
Dr Nanshan Zhong, 83, an internationally renowned respiratory specialist and member of the Chinese Academy of Engineering, was a pioneer in the fight against SARS in 2013 and is now the chief expert on COVID-19 prevention with the Chinese National Health Commission. Dr. Nanshan Zhong has been fighting on the front line of the coronavirus epidemic since he reported the first person-to-person transmission of COVID-19 in January.
Since the onset of the coronavirus epidemic, Huami has continued its efforts to "connect health to technology". The company has donated RMB 11.5 million worth of medical supplies and equipment since the start of the epidemic. Huami also developed a smart watch for medical personnel in Wuhan , which has a function to alleviate psychological distress.
Related Industry Updates
Cosmetic Surgery: Guide to Procedures & What to Know
Mar 23, 2026
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Apr 30, 2020
Cryotherapy Market Business Opportunity 2021 – Top Companies : ZIMMER MEDIZINSYSTEME GMBH,Impact Cryotherapy.,CryoConcepts LP,MEDTRONIC,METRUM CRYOFLEX Ltd & More
May 12, 2021
Mobile COVID-19 testing set for Leake and Hinds counties
May 20, 2020
Asia Pacific Companion Animal Diagnostics Market Research Along With COVID-19 Impact Analysis, Advancement and Outlook 2027| Fujifilm Corporation, Skyla Corporation, Virbac
Nov 30, 2020
PSA Test Explained: What It Is, How It Works, and Why It Matters
Mar 27, 2026
Almost 9.6 Million Deaths Across the Globe Were Due to Cancer: Who
Oct 04, 2019